BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15465558)

  • 21. Eyelid contracture may indicate recurrent basal cell carcinoma, even after Mohs' micrographic surgery.
    Ong LY; Lane CM
    Orbit; 2009; 28(1):29-33. PubMed ID: 19229742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital invasion by periocular basal cell carcinoma.
    Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
    Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
    Cook BE; Bartley GB
    Ophthalmology; 1999 Apr; 106(4):746-50. PubMed ID: 10201597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma.
    Then SY; Malhotra R; Barlow R; Kurwa H; Huilgol S; Joshi N; Olver J; Collin R; Selva D
    Dermatol Surg; 2009 Jan; 35(1):17-23. PubMed ID: 19076193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery.
    Spencer JM; Nossa R; Tse DT; Sequeira M
    J Am Acad Dermatol; 2001 Jun; 44(6):1004-9. PubMed ID: 11369914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
    Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
    Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periocular Squamous Cell Carcinoma: TNM Staging and Recurrence.
    Sun MT; Andrew NH; O'Donnell B; McNab A; Huilgol SC; Selva D
    Ophthalmology; 2015 Jul; 122(7):1512-6. PubMed ID: 25972255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basosquamous carcinoma: treatment with Mohs micrographic surgery.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    Cancer; 2005 Jul; 104(1):170-5. PubMed ID: 15929123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Australian Mohs database: short-term recipient-site complications in full-thickness skin grafts.
    Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
    Dermatol Surg; 2006 Nov; 32(11):1364-8. PubMed ID: 17083589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified Mohs micrographic surgery for periocular melanoma and melanoma in situ: long-term experience at Scripps Clinic.
    Shumaker PR; Kelley B; Swann MH; Greenway HT
    Dermatol Surg; 2009 Aug; 35(8):1263-70. PubMed ID: 19438663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
    Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
    Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
    Thomas CJ; Wood GC; Marks VJ
    Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
    Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
    Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mohs surgery vs primary excision for eyelid BCCs.
    Tildsley J; Diaper C; Herd R
    Orbit; 2010 Jun; 29(3):140-5. PubMed ID: 20497079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
    Spraul CW; Ahr WM; Lang GK
    Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of periocular basal cell carcinoma managed by overnight paraffin section.
    Khandwala MA; Lalchan SA; Chang BY; Habib M; Chakrabarty A; Cassells-Brown A
    Orbit; 2005 Dec; 24(4):243-7. PubMed ID: 16354633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.